Oncolytics Biotech® Presents Positive Interim Safety Update from Phase 2 Triple-Negative Breast Cancer Trial at the 2021 San Antonio Breast Cancer Symposium

Stock Information for Oncolytics Biotech Inc.

Loading

Please wait while we load your information from QuoteMedia.